These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5009710)

  • 1. Effects of dialysate calcium and fluoride on bone disease during regular hemodialysis.
    Jowsey J; Johnson WJ; Taves DR; Kelly PJ
    J Lab Clin Med; 1972 Feb; 79(2):204-14. PubMed ID: 5009710
    [No Abstract]   [Full Text] [Related]  

  • 2. Dialysis bone disease. A quantitative histologic study.
    Binswanger U; Sherrard D; Rich C; Curtis FK
    Nephron; 1974; 12(1):1-9. PubMed ID: 4838006
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of variations in calcium intake on the skeleton of fluoride-fed kittens.
    Burkhart JM; Jowsey J
    J Lab Clin Med; 1968 Dec; 72(6):943-50. PubMed ID: 5723117
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone disease in hemodialysis patients with particular reference to the effect of fluoride.
    Cordy PE; Gagnon R; Taves DR; Kaye M
    Can Med Assoc J; 1974 Jun; 110(12):1349-53. PubMed ID: 4834525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoride metabolism in uremia.
    Nielsen E; Solomon N; Goodwin NJ; Siddhivarn N; Galonsky R; Taves D; Friedman EA
    Trans Am Soc Artif Intern Organs; 1973; 19():450-5. PubMed ID: 4722761
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled evaluation of clinical and metabolic effects of dialysate calcium levels during regular hemodialysis.
    Mirahmadi KS; Duffy BS; Shinaberger JH; Jowsey J; Massry SG; Coburn JW
    Trans Am Soc Artif Intern Organs; 1971; 17():118-24. PubMed ID: 5158077
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phosphate binging agents on bone remodelling in patients on regular haemodialysis.
    Fournier A; Tunchot S; Bedrossian J; Sionest JG; Idatte JM; Bordier P
    Proc Eur Dial Transplant Assoc; 1972; 9():126-41. PubMed ID: 4668905
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients.
    Fiedler R; Deuber HJ; Langer T; Osten B; Mohan S; Jehle PM
    Nephron Clin Pract; 2004; 96(1):c3-9. PubMed ID: 14752247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological assessment of endemic skeletal fluorosis.
    Faccini JM; Teotia SP
    Calcif Tissue Res; 1974; 16(1):45-57. PubMed ID: 4447889
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone disease in hemodialysis patients with particular reference to the effect of fluoride.
    Cordy PE; Gagnon R; Taves DR; Kaye M
    Trans Am Soc Artif Intern Organs; 1974; 20A():197-202. PubMed ID: 4450338
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in skeletal mineral in patients on prolonged maintenance dialysis.
    Atkinson PJ; Hancock DA; Acharya VN; Parsons FM; Proctor EA; Reed GW
    Br Med J; 1973 Dec; 4(5891):519-22. PubMed ID: 4357138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoride and dialysis osteodystrophy: results of a double-blind study.
    Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA
    Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of fluoride, calcium, and phosphorus on porcine bone.
    Spencer GR; el-Sayed FI; Kroening GH; Pell KL; Shoup N; Adams DF; Franke M; Alexander JE
    Am J Vet Res; 1971 Nov; 32(11):1751-74. PubMed ID: 5166189
    [No Abstract]   [Full Text] [Related]  

  • 14. Total body calcium and long-term calcium balance in chronic renal disease.
    Denney JD; Sherrard DJ; Nelp WB; Chesnut CH; Baylink DJ
    J Lab Clin Med; 1973 Aug; 82(2):226-40. PubMed ID: 4721378
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of lowering dialysate calcium concentration on mineral metabolism and hemodynamic parameters in hemodialysis patients.
    Alayoud A; El Kabbaj D; Benyahia M; Asseraji M; Zemraoui N
    Iran J Kidney Dis; 2015 Mar; 9(2):132-7. PubMed ID: 25851292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone histological changes occurring after haemodialysis treatment for chronic renal failure.
    Woods CG; Bishop MC; Nicholson GD
    J Pathol; 1972 Jun; 107(2):137-43. PubMed ID: 5074827
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evolution of bone lesions in repeated hemodialysis].
    Meyrier A; Marsac J; Billard D; Richet G
    Ann Med Interne (Paris); 1973 Feb; 124(2):85-90. PubMed ID: 4723746
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoridated water, hemodialysis, and renal disease.
    Med Lett Drugs Ther; 1969 Aug; 11(16):67-8. PubMed ID: 5820566
    [No Abstract]   [Full Text] [Related]  

  • 19. Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines.
    Izumi M; Shirai K; Ito K; Miyamoto T; Matsumoto A; Takenaka Y; Nakagawa K; Yamanashi T; Takamitsu Y; Nakanish T
    Ther Apher Dial; 2005 Feb; 9(1):24-31. PubMed ID: 15828902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of renal osteodystrophy in patients dialyzed with deionized and non-deionized water.
    Posen GA; Gray DG; Jaworski ZF; Couture R; Rashid A
    Trans Am Soc Artif Intern Organs; 1972; 18(0):405-11. PubMed ID: 4610968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.